Pulike Biological Engineering, Inc. (SHA:603566)
China flag China · Delayed Price · Currency is CNY
13.82
-0.08 (-0.58%)
At close: Feb 13, 2026

SHA:603566 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,0951,0341,2431,2171,088917.41
Other Revenue
8.698.6910.1113.0611.0311.1
1,1041,0431,2531,2301,099928.51
Revenue Growth (YoY)
1.65%-16.77%1.84%11.97%18.32%40.01%
Cost of Revenue
450.36405.63488.4459.74379.95331.25
Gross Profit
653.47636.93764.3770.33718.62597.26
Selling, General & Admin
377.36413.65450.03473.74391.87292.77
Research & Development
104.42106.05101.192.6285.57114.84
Other Operating Expenses
23.7716.614.6212.7711.2910.34
Operating Expenses
495.04531.02593.41594.47496.51427.25
Operating Income
158.43105.91170.89175.86222.11170.02
Interest Expense
-1.78-0.08-0.92-0.86--
Interest & Investment Income
-4.821.7910.092.515.03
Currency Exchange Gain (Loss)
0.190.190.220.58-0.22-0.02
Other Non Operating Income (Expenses)
-3.2-0.78-0.73-0.65-0.560.1
EBT Excluding Unusual Items
153.64110.03191.25185.02223.84185.12
Gain (Loss) on Sale of Investments
-8.69-9.97-17.69-25.5720.3924.32
Gain (Loss) on Sale of Assets
-12.71-12.27-0.6-0.54-3.340.29
Asset Writedown
0.83-1-0.03---
Other Unusual Items
24.9311.9821.6818.8143.2850.28
Pretax Income
15898.76194.61177.72284.18260
Income Tax Expense
14.335.9620.19.940.0432.26
Net Income
143.6792.81174.52167.82244.14227.74
Net Income to Common
143.6792.81174.52167.82244.14227.74
Net Income Growth
41.30%-46.82%3.99%-31.26%7.20%108.47%
Shares Outstanding (Basic)
343344349323313316
Shares Outstanding (Diluted)
343344349323313316
Shares Change (YoY)
-1.44%-1.52%8.15%3.11%-1.05%-1.56%
EPS (Basic)
0.420.270.500.520.780.72
EPS (Diluted)
0.420.270.500.520.780.72
EPS Growth
43.36%-46.00%-3.85%-33.33%8.33%111.77%
Free Cash Flow
337.75147.73-22.2-128.8-105.0184.69
Free Cash Flow Per Share
0.980.43-0.06-0.40-0.340.27
Dividend Per Share
0.6000.4000.7000.3500.2000.500
Dividend Growth
50.00%-42.86%100.00%75.00%-60.00%150.00%
Gross Margin
59.20%61.09%61.01%62.63%65.41%64.33%
Operating Margin
14.35%10.16%13.64%14.30%20.22%18.31%
Profit Margin
13.02%8.90%13.93%13.64%22.22%24.53%
Free Cash Flow Margin
30.60%14.17%-1.77%-10.47%-9.56%9.12%
EBITDA
298.27225.17262.7249.8281.42221.07
EBITDA Margin
27.02%21.60%20.97%20.31%25.62%23.81%
D&A For EBITDA
139.84119.2691.8173.9359.3151.05
EBIT
158.43105.91170.89175.86222.11170.02
EBIT Margin
14.35%10.16%13.64%14.30%20.22%18.31%
Effective Tax Rate
9.07%6.03%10.33%5.57%14.09%12.41%
Revenue as Reported
1,1041,0431,2531,2301,099928.51
Advertising Expenses
-10.275.547.627.546.19
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.